OBSIDIAN THERAPEUTICS

Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy to every patient with cancer.The company's next-generation cell and gene therapies with pharmacologic operating systems provide exquisite control of protein activity in cells and create adoptive cell therapies with new functions that are under control of the treating physician using simple, safe, orally-active, marketed drugs, enabling patients to improve on the current generation of cell therapies.

#SimilarOrganizations #People #Financial #Website #More

OBSIDIAN THERAPEUTICS

Social Links:

Twitter

Industry:

Biotechnology Health Care Pharmaceutical

Founded:

2015-01-01

Address:

Cambridge, Massachusetts, United States

Country:

United States

Website Url:

http://www.obsidiantx.com

Total Employee:

51+

Status:

Active

Contact:

(781) 806-6245

Email Addresses:

[email protected]

Total Funding:

164.5 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Global Site Tag Sitelinks Search Box Amazon

Similar Organizations

ankyra-logo

Ankyra

Ankyra is developing a platform to significantly improve both the safety and efficacy of cytokine immunotherapies for cancer.

aratana-therapeutics-logo

Aratana Therapeutics

Aratana Therapeutics develops innovative therapies for the animal health industry.

bwell-connected-health-logo

b.well Connected Health

b.well Connected Health provides an integrated solution for consumer engagement, holistic health management, and cost containment.

carerx-logo

CareRx

CareRx is a provider of pharmacy services to seniors communities.

century-therapeutics-logo

Century Therapeutics

Century Therapeutics is a developer of allogeneic living drugs created to offer treatment for cancer.

cybin-logo

Cybin

Cybin is a life sciences company dedicated in advancing psychedelic therapeutics with the goal of transforming mental healthcare.

denteric-logo

Denteric

Denteric is developing a vaccine based on research conducted at the University of Melbourne.

dracen-pharmaceuticals-logo

Dracen Pharmaceuticals

Dracen Pharmaceuticals is a developer of novel glutamine antagonists created to deliver improved outcomes for cancer patients.

dyne-therapeutics-logo

Dyne Therapeutics

Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.

eip-pharma-logo

EIP Pharma

EIP Pharma Provides Healthcare Services.

everest-medicines-logo

Everest Medicines

Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients.

genomic-prediction-logo

Genomic Prediction

Genomic Prediction provides advanced genetic testing for IVF.

icosavax-logo

Icosavax

Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.

jaguar-health-logo

Jaguar Health

Jaguar Health brings naturally derived important health solutions to all animals of the world, as proprietary.

kalderos-logo

Kalderos

Kalderos provides a SaaS based drug discount management solution, which identifies, checks, and resolves non-compliance.

neukio-biotherapeutics-logo

Neukio Biotherapeutics

Neukio Biotherapeutics is a developer of allogenic immune cell therapies for treatment of cancer.

nivien-therapeutics-logo

Nivien Therapeutics

Nivien Therapeutics is developing the first small molecule drugs to enhance both chemo and immunotherapies.

pyxis-oncology-logo

Pyxis Oncology

Pyxis Oncology is a developer of antibody therapeutics intended to promote the body's immune response to cancer.

sante-basque-developpement-logo

Sante Basque Developpement

Sante Basque Developpement is owns and operates mental health hospitals.

syndesi-therapeutics-logo

Syndesi Therapeutics

Syndesi Therapeutics develops a drug candidate for the treatment of consecutive cognitive disorders of various neurological conditions.

tiburio-therapeutics-logo

Tiburio Therapeutics

Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.

tune-therapeutics-logo

Tune Therapeutics

Tune Therapeutics is an epigenetic programming platform for the treatment of disease.

vico-therapeutics-logo

Vico Therapeutics

Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies.

westlake-therapeutics-logo

Westlake Therapeutics

The company is committed to the development of a variety of innovative cell therapy products for rare diseases, cancer, etc.

zucara-therapeutics-logo

Zucara Therapeutics

Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in patients with diabetes.

Current Advisors List

cariad-chester_image

Cariad Chester Board Member @ Obsidian Therapeutics
Board_member

Current Employees Featured

michael-gilman_image

Michael Gilman
Michael Gilman Founder & CEO @ Obsidian Therapeutics
Founder & CEO

steve-shamah_image

Steve Shamah
Steve Shamah Senior Vice President & Head of Research @ Obsidian Therapeutics
Senior Vice President & Head of Research
2016-09-01

jan-ter-meulen_image

Jan Ter Meulen
Jan Ter Meulen CSO @ Obsidian Therapeutics
CSO

paul-wotton_image

Paul Wotton
Paul Wotton CEO @ Obsidian Therapeutics
CEO

parnian-zia-amirhosseini_image

Parnian Zia-Amirhosseini
Parnian Zia-Amirhosseini VP and Head of Regulatory Affairs & Quality Assurance @ Obsidian Therapeutics
VP and Head of Regulatory Affairs & Quality Assurance

catherine-stehman-breen_image

Catherine Stehman-Breen
Catherine Stehman-Breen CDO @ Obsidian Therapeutics
CDO

karen-brown_image

Karen Brown
Karen Brown SVP of Intellectual Property and Legal Affairs @ Obsidian Therapeutics
SVP of Intellectual Property and Legal Affairs

kirsten-kester_image

Kirsten Kester
Kirsten Kester Senior Vice President, Business Development @ Obsidian Therapeutics
Senior Vice President, Business Development
2022-01-01

ryan-daws_image